Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Transmembrane protein 230 pseudogene (ENSG00000271385) is a nonfunctional, noncoding genomic sequence highly similar to the protein-coding TMEM230 gene. Pseudogenes typically contain mutations or disruptions that preclude expression of a functional protein. While some pseudogenes can exert regulatory effects on gene expression, most are not direct therapeutic targets and do not produce proteins. This entry should not be confused with the functional TMEM230 gene, which encodes a neuronal vesicle trafficking protein involved in Parkinson's disease and cancer[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 230 pseudogene.